Our genes affect how we react to medications. A drug that works for one person, can be ineffective or cause side effects for another. With pharmacogenetic testing your doctor can predict your response to different drugs and offer safer and more effective medication for you individually. Pharmacogenetic testing enables precision medication in e.g. cardiology, neurology and psychiatry.
Scientific evidence shows that clinically significant adverse drug reactions (ADR) are reduced by 30% if the attending physician has the results of a pharmacogenetic test to support medication decision-making.
Healthcare providers and laboratories offer pharmacogenetic testing. You can also use our home sample collection kit.
We at Abomics support doctors in daily clinical decision-making. The Abomics pharmacogenetic interpretation service enables laboratories to complement DNA test results with an interpretation report that is designed for doctors. The pharmacogenetic interpretation report includes clear recommendations for determining a drug and dosage that is suitable for the patient in question. Together with our subsidiary Multirec, we also offer medical databases on pharmaceuticals, drug indications, drug-drug interactions, pharmacogenetic gene-drug interrelationships etc. These databases are available for integrations with electronic health record (EHR) and prescription systems and other software and databases. The databases support doctors’ decision-making and enable smooth and efficient prescription and medication evaluation workflows. Database information enables evidence-based, effective, and efficient decision-making in clinical practice and supports effective and safe medication.
Abomics Oy is a Finnish company specialised in offering tools to support doctors’ decision-making. We are based in Finland and offer pharmacogenetic solutions for clinical laboratories, healthcare providers and healthcare IT and software companies.